Congratulations to Xunfei Healthcare Technology Co., Ltd. (2506.HK) on its successful Listing on the Mainboard of HKSE on 30 December 2024
Xunfei Healthcare Technology Co., Ltd. (“Xunfei Healthcare”) is an AI-empowered healthcare solution provider committed to empowering the healthcare industry with AI technologies and realizing large-scale commercialization of healthcare AI solutions in China. The Company’s products and solutions support a range of healthcare services, ranging from health risk warnings, early screening, auxiliary diagnosis and treatment as well as treatment effect evaluation to post-discharge management and chronic disease management.
With regard to this listing application, AVISTA Group is honored to be engaged in providing valuation services on expected credit loss, goodwill impairment and development expenses impairment.
Congratulations again to Xunfei Healthcare Technology Co., Ltd. (2506.HK) on its successful listing. The issue price is HKD 82.80 per share, and the amount of funds raised is HKD 583 million.
Meet Our People
VINCENT PANG
Managing Partner
AVISTA GROUP
vincent.pang@avaval.com
HAILEY JIN
Partner
VALUATION ADVISORY
hailey.jin@avaval.com
IRENE MA
Associate Director
VALUATION ADVISORY
irene.ma@avaval.com
Date: 30 Dec 2024 | Tags: Initial Public Offering (IPO)
Latest News